Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
107,809,066
-
Total 13F shares
-
33,462,480
-
Share change
-
+2,481,388
-
Total reported value
-
$569,908,589
-
Put/Call ratio
-
69%
-
Price per share
-
$17.08
-
Number of holders
-
142
-
Value change
-
+$44,514,644
-
Number of buys
-
67
-
Number of sells
-
45
Institutional Holders of Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA) as of Q1 2019
As of 31 Mar 2019 Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA) had 142 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 33,462,480 shares of stock of the company.
Largest 10 holders included ARK Investment Management LLC, BlackRock Inc., VANGUARD GROUP INC, FMR LLC, MORGAN STANLEY, STATE STREET CORP, ONTARIO TEACHERS PENSION PLAN BOARD, Atlas Venture Associates IX, LLC, Nikko Asset Management Americas, Inc., and Sumitomo Mitsui Trust Holdings, Inc..
This table shows 142 institutional shareholders of the security as of 31 Mar 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.